Navigation Links
Average Medicare Prescription Drug Premiums to Rise 21%
Date:10/5/2007

WASHINGTON, Oct. 5 /PRNewswire/ -- If consumers stay put in their current Medicare prescription drug plans, the average beneficiary will see a 21% increase in their monthly premiums for 2008, says new analysis released by Avalere Health.

Using newly released CMS data and its proprietary DataFrame(R) database, Avalere experts computed an "enrollment weighted" average premium for the Medicare Part D marketplace. Under this method, the premiums of plans with the most enrollees are assigned a heavier weight relative to plans with scant enrollment, giving a truer measure of the beneficiary experience. For example, a premium increase for a prescription drug plan (PDP) with 3 million enrollees carries vastly greater impact on more people than a premium increase for a plan with 10,000 enrollees.

"The reality of the Medicare experience is that beneficiaries have been very loyal thus far to their initial plan selections," said Dan Mendelson, president of Avalere Health. "If consumers stick to their choices again, they are likely to see a dramatic increase in their monthly premiums. But, consumers who shop around may be able to find lower cost alternatives."

The top ten PDP sponsors in Medicare have more than 80% of the people enrolled in stand-alone PDPs. Among those top ten plan sponsors, all have raised their premiums, with the exception of two: CVS Caremark's SilverScript plan and First Health's Part D Premier plan. Using Avalere's enrollment-weighted premium methodology, the Humana PDP Standard (currently with the second-most enrollment) raised its premium an average of 69%. The largest increase -- 89% -- is in United's Medicare Rx AARP Plan-Saver PDP, which as of July 2007 had over more 900,000 enrollees.

"The shift in premiums from year to year reflects a close calibration by the plan sponsors to maintain customer loyalty, remain competitively priced, and achieve profitability," said Bob Atlas, senior vice president of Avalere Health.

Avalere will continue to analyze Medicare drug benefit data as it is publicly released. Since the inception of the Medicare drug program, Avalere has used its DataFrame(R) database to track trends in drug pricing, plan strategy and structure, and the beneficiary experience. For more information on DataFrame(R) and Avalere's analytic capabilities, contact Brian Bruen, bbruen@avalerehealth.net.


'/>"/>
SOURCE Avalere Health
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. HIV Prevalence In Ethiopian Women Greater Than National Average
2. Average Age of Diabetics Smaller in China
3. Delhis Morbidity Rate Nearly One-sixth of National Average
4. Medicare Drug Deadline not to be extended
5. House heads for Medicare drug vote
6. New Medicare Plan - Mixed Reaction among Pharmacists.
7. Medicare Data would help in Drug Validation
8. Medicare Queries Expected To Increase Over Time
9. Medicare to cover services provided by rural health care personnels.
10. Cancer test expenses taken up by Medicare
11. Nurse Practitioners Are Not Recognized By Medicare
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/28/2017)... ... June 28, 2017 , ... Schneider Insurance and ... to clients in southern Montana, is announcing a focused charity effort to gather ... outreach programs offered by Zoo Montana provide students with current knowledge on the ...
(Date:6/27/2017)... , ... June 27, 2017 , ... ... the appointment of Mike Finnegan to the position of Executive Vice President, Sales ... experience in healthcare technology, telehealth and medical device sales leadership. He has received ...
(Date:6/27/2017)... , ... June 27, 2017 , ... ... solution for many of the health care industry’s hospitals and provider groups, has ... financing portal for select customers. Parasail Health is a San Francisco health-finance startup ...
(Date:6/27/2017)... , ... June 27, 2017 , ... A January 18th ... projected to reach a staggering $6.81 billion by the year 2024 according to a ... a faster rate than those made from titanium. Los Angeles area clinic Beverly Hills ...
(Date:6/27/2017)... ... 2017 , ... Atmosera , a premier Microsoft Cloud ... . The trusted, transparent, and secure solution for the cloud enablement of business ... next generation services include integrated capabilities for public, private, and hybrid Azure cloud ...
Breaking Medicine News(10 mins):
(Date:6/14/2017)... 2017  ivWatch LLC, a medical device company focused ... therapy, is pleased to announce it was the Bronze ... Supplies and Equipment at the 2017 Medical Design Excellence ... industry. The award was presented by Medical Device and ... in New York during MD&M ...
(Date:6/11/2017)... 2017  Eli Lilly and Company (NYSE: LLY ... studies of galcanezumab, an investigational treatment for the prevention ... several key secondary endpoints for galcanezumab compared to placebo ... (EVOLVE-1, EVOLVE-2 and REGAIN) will be presented today at ... Boston . "The ...
(Date:6/8/2017)... June 8, 2017   Responding to Heath Ledger,s ... the death of singer Chris Cornell in May, ... International offers a free online psychiatric drug ... and families about psychotropic drug risks. The ... died from an accidental overdose, has called for tighter rules ...
Breaking Medicine Technology: